The nation of Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive information.
This move was revealed after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative has since clarified that the United States was seeking health data for scientific study and commercial gain while was not willing to share the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more talks to reach a deal acceptable to both sides so the nation's vital HIV programme can be sustained.
Broader Implications
This development follows a similar case in Kenya, where a high court blocked a related health funding agreement after concerns were filed about the security of Kenyans' health data.
After returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral deals to boost openness and responsibility.
Based on statements, 16 nations in Africa have to date signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment via American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the final treatments would be available to our population should a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting structures previously established through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a nation provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing discussions with our US partners on how subsequent collaboration might be designed in a way that honours the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body said it acknowledged the government's concerns, but suggested that negotiations must proceed given that much of the nation's HIV programmes relied on foreign aid.
"Where technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it added.
The halted deal highlights the ongoing debate between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.